Atlas Trials

Subventricular Zone (SVZ) and Temozolomide in Glioblastoma Multiforme

Clinical trial NCT02177578 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT02177578
Sponsor
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Glioblastoma Multiforme
Start date
2014-07-08
Primary completion
2026-08-01
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.